Supernus Pharmaceuticals Inc (SUPN) US$0.001

Sell:$32.37Buy:$32.49$0.18 (0.56%)

NASDAQ:0.27%
Prices delayed by at least 15 minutes
Sell:$32.37
Buy:$32.49
Change:$0.18 (0.56%)
Prices delayed by at least 15 minutes
Sell:$32.37
Buy:$32.49
Change:$0.18 (0.56%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 March 2025
Jack A KhattarChairman/CEO
Sell
Tax related
16,805$32.06$538,768.30991,833
10 March 2025
Timothy C DecCFO
Sell
Tax related
955$32.06$30,617.3012,681
10 March 2025
Timothy C DecCFO
Sell
Tax related
1,062$32.06$34,047.7211,836
7 March 2025
Jack A KhattarChairman/CEO
Sell
Tax related
18,581$39.11$726,702.91973,638
7 March 2025
Frank MottolaSenior Vice President
Sell
Tax related
1,356$39.11$53,033.1615,151
5 March 2025
Frank MottolaSenior Vice President
Sell
Tax related
337$33.05$11,137.8515,437
5 March 2025
Frank MottolaSenior Vice President
Sell
Tax related
610$33.05$20,160.5014,827
5 March 2025
Frank MottolaSenior Vice President
Sell
Tax related
945$33.05$31,232.2513,882
5 March 2025
Padmanabh P BhattChief Level Officer
Sell
Tax related
335$33.05$11,071.7513,854
5 March 2025
Timothy C DecCFO
Sell
Tax related
276$33.05$9,121.8013,815

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
7 November 2024
Jack A KhattarChairman/CEO
Sell
Option/Award related
125,000$36.68$4,585,000.00926,172
8 November 2024
Jack A KhattarChairman/CEO
Sell
Option/Award related
125,000$36.29$4,536,250.00926,172
7 March 2025
Jack A KhattarChairman/CEO
Sell
Tax related
18,581$39.11$726,702.91973,638
27 December 2024
Jack A KhattarChairman/CEO
Sell
Tax related
18,567$35.59$660,799.53946,245
7 November 2024
Frank MottolaSenior Vice President
Sell
Option/Award related
15,000$36.98$554,700.008,200

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.